Ambipar Emergency Response Stock Today
| AMBI Stock | USD 5.15 0.35 7.29% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Ambipar Emergency is trading at 5.15 as of the 24th of March 2025. This is a 7.29 percent increase since the beginning of the trading day. The stock's open price was 4.8. Ambipar Emergency has about a 36 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 24th of December 2024 and ending today, the 24th of March 2025. Click here to learn more.
Business Domain Commercial & Professional Services | IPO Date 3rd of March 2023 | Category Industrials |
Ambit Biosciences Corporationration, a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of oncology, autoimmune, and inflammatory diseases in the United States. The company has 16.2 M outstanding shares of which 2.04 K shares are presently shorted by private and institutional investors with about 0.3 trading days to cover. More on Ambipar Emergency Response
Moving together with Ambipar Stock
| 0.74 | BV | BrightView Holdings | PairCorr |
| 0.65 | FC | Franklin Covey Earnings Call Tomorrow | PairCorr |
| 0.66 | NL | NL Industries | PairCorr |
Moving against Ambipar Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Ambipar Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President America | Shannon Riley | ||||
| Thematic Ideas | (View all Themes) | ||||
| Business Concentration | Environmental & Facilities Services, Commercial & Professional Services, Industrials, Management, Recycling, Industrials, Commercial Services & Supplies, Pharmaceutical Products, Industrials (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Ambipar Emergency can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Ambipar Emergency's financial leverage. It provides some insight into what part of Ambipar Emergency's total assets is financed by creditors.
| |||||
Ambipar Emergency Response (AMBI) is traded on NYSE MKT Exchange in USA. It is located in Avenida AngElica, no 2346, São Paulo, SP, Brazil, 01228-200 and employs 7,500 people. Ambipar Emergency is listed under Environmental & Facilities Services category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 318.59 M. Ambipar Emergency conducts business under Commercial Services & Supplies sector and is part of Industrials industry. The entity has 16.2 M outstanding shares of which 2.04 K shares are presently shorted by private and institutional investors with about 0.3 trading days to cover.
Ambipar Emergency Response currently holds about 52.8 M in cash with 78.48 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.93.
Check Ambipar Emergency Probability Of Bankruptcy
Ownership AllocationAmbipar Emergency holds a total of 16.2 Million outstanding shares. Ambipar Emergency Response shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 84.26 percent of Ambipar Emergency outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Ambipar Ownership Details
Ambipar Emergency Historical Income Statement
Ambipar Stock Against Markets
Already Invested in Ambipar Emergency Response?
The danger of trading Ambipar Emergency Response is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Ambipar Emergency is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Ambipar Emergency. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Ambipar Emergency is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Ambipar Emergency offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ambipar Emergency's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ambipar Emergency Response Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ambipar Emergency Response Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ambipar Emergency Response. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Environmental & Facilities Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ambipar Emergency. If investors know Ambipar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ambipar Emergency listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share 0.13 | Revenue Per Share | Quarterly Revenue Growth 0.578 | Return On Assets |
The market value of Ambipar Emergency is measured differently than its book value, which is the value of Ambipar that is recorded on the company's balance sheet. Investors also form their own opinion of Ambipar Emergency's value that differs from its market value or its book value, called intrinsic value, which is Ambipar Emergency's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ambipar Emergency's market value can be influenced by many factors that don't directly affect Ambipar Emergency's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ambipar Emergency's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ambipar Emergency is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ambipar Emergency's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.